Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study

References

• Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973;136(4):602–606.4632149
   PubMedGoogle Scholar
• Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979;148(6):871–875.109934
   PubMedGoogle Scholar
• Gyves J, Ensminger W, Niederhuber J, et al. Totally implanted system for intravenous chemotherapy in patients with cancer. Am J Med. 1982;73(6):841–845. doi:10.1016/0002-9343(82)90774-46959532
   PubMed Web of Science ®Google Scholar
• Kreis H, Loehberg CR, Lux MP, et al. Patients’ attitudes to totally implantable venous access port systems for gynecological or breast malignancies. Eur J Surg Oncol. 2007;33(1):39–43.17029869
   PubMed Web of Science ®Google Scholar
• Ignatov A, Hoffman O, Smith B, et al. An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. Eur J Surg Oncol. 2009;35(3):241–246.18329836
   PubMed Web of Science ®Google Scholar
• Geerts W. Central venous catheter-related thrombosis. Hematology Am Soc Hematol Educ Program. 2014;2014(1):306–311.25696870
   PubMedGoogle Scholar
• Lee AY, Levine MN, Butler G, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol. 2006;24(9):1404–1408.16549834
   PubMed Web of Science ®Google Scholar
• Saber W, Moua T, Williams EC, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost. 2011;9(2):312–319.21040443
   PubMed Web of Science ®Google Scholar
• Plumhans C, Mahnken AH, Ocklenburg C, et al. Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception. Eur J Radiol. 2011;79(3):338–342.20227211
   PubMed Web of Science ®Google Scholar
• Leung A, Heal C, Perera M, Pretorius C. A systematic review of patient-related risk factors for catheter-related thrombosis. J Thromb Thrombolysis. 2015;40(3):363–373. doi:10.1007/s11239-015-1175-925680892
   PubMed Web of Science ®Google Scholar
• Oberhoff C, Szymeczek J, Hoffmann O, Winkler UH, Kaiser S, Schindler AE. Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis. Breast Cancer Res Treat. 1998;50(1):73–81.9802622
   PubMed Web of Science ®Google Scholar
• Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008;111(10):4902–4907. doi:10.1182/blood-2007-10-11632718216292
   PubMed Web of Science ®Google Scholar
• Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol. 2003;21(19):3665–3675. doi:10.1200/JCO.2003.08.00814512399
   PubMed Web of Science ®Google Scholar
• Biffi R, Orsi F, Pozzi S, et al. Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial. Ann Oncol. 2009;20(5):935–940. doi:10.1093/annonc/mdn70119179550
   PubMed Web of Science ®Google Scholar
• Heibl C, Trommet V, Burgstaller S, et al. Complications associated with the use of port-a-caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care (Engl). 2010;19(5):676–681. doi:10.1111/j.1365-2354.2009.01115.x19708941
   PubMed Web of Science ®Google Scholar
• Decousus H, Bourmaud A, Fournel P, et al. Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP). Blood. 2018;132(7):707–716. doi:10.1182/blood-2018-03-83715329980524
   PubMed Web of Science ®Google Scholar
• Biffi R, Pozzi S, Agazzi A, et al. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol. 2004;15(2):296–300. doi:10.1093/annonc/mdh04914760125
   PubMed Web of Science ®Google Scholar
• Orlando L, Colleoni M, Nole F, et al. Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required? Ann Oncol. 2000;11(1):117–118. doi:10.1023/a:1008364801718
   PubMed Web of Science ®Google Scholar
• Levine M, Hirsh J, Gent M, et al. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet (London, England). 1994;343(8902):886–889. doi:10.1016/s0140-6736(94)90008-6
   PubMed Web of Science ®Google Scholar
• Curigliano G, Balduzzi A, Cardillo A, et al. Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter. Support Care Cancer. 2007;15(10):1213–1217. doi:10.1007/s00520-007-0277-017578607
   PubMed Web of Science ®Google Scholar
• Janahi EM. Prevalence and risk factors of hepatitis B virus infection in Bahrain, 2000 through 2010. PLoS One. 2014;9(2):e87599. doi:10.1371/journal.pone.008759924498341
   PubMed Web of Science ®Google Scholar
• Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354(10):1001–1010. doi:10.1056/NEJMoa05128516525137
   PubMed Web of Science ®Google Scholar
• Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354(10):1011–1020. doi:10.1056/NEJMoa05128716525138
   PubMed Web of Science ®Google Scholar
• Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007;357(25):2576–2588. doi:10.1056/NEJMoa06642218094378
   PubMed Web of Science ®Google Scholar
• Xiang DZ, Verbeken EK, Van Lommel AT, Stas M, De Wever I. Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg. 1998;28(2):260–271. doi:10.1016/s0741-5214(98)70162-49719321
   PubMed Web of Science ®Google Scholar
• Mason A, Wick M, White H, Perrillo R. Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology (Baltimore, Md). 1993;18(4):781–789.
   PubMedGoogle Scholar
• Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit. 2010;16(4):Cr202–Cr205.20357720
   PubMed Web of Science ®Google Scholar
• Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013;122(10):1712–1723. doi:10.1182/blood-2013-04-46012123908465
   PubMed Web of Science ®Google Scholar
• Pabinger I, Posch F. Flamethrowers: blood cells and cancer thrombosis risk. Hematology Am Soc Hematol Educ Program. 2014;2014(1):410–417. doi:10.1182/asheducation-2014.1.41025696887
   PubMedGoogle Scholar
• Connolly GC, Phipps RP, Francis CW. Platelets and cancer-associated thrombosis. Semin Oncol. 2014;41(3):302–310. doi:10.1053/j.seminoncol.2014.04.00925023346
   PubMed Web of Science ®Google Scholar
• von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–835. doi:10.1084/jem.2011232222451716
   PubMed Web of Science ®Google Scholar
• Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 2013;122(11):1873–1880. doi:10.1182/blood-2013-04-46013923798713
   PubMed Web of Science ®Google Scholar
• Cheng Y, Cui T, Fu P, Liu F, Zhou L. Dyslipidemia is associated with tunneled-cuffed catheter-related central venous thrombosis in hemodialysis patients: a retrospective, multicenter study. Artif Organs. 2013;37(8):E155–E161. doi:10.1111/aor.1208623634689
   PubMed Web of Science ®Google Scholar
• Garcia Raso A, Ene G, Miranda C, Vidal R, Mata R, Llamas Sillero MP. [Association between venous thrombosis and dyslipidemia]. Med Clin (Barc). 2014;143(1):1–5. doi:10.1016/j.medcli.2013.07.024
   PubMed Web of Science ®Google Scholar
• Hsu SH, Jang MH, Torng PL, Su TC. Positive association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation, thrombosis, and prediabetes in non-diabetic adults. J Atheroscler Thromb. 2019 Jul 1;26(7):624-635.
   Web of Science ®Google Scholar
• Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117(1):93–102. doi:10.1161/CIRCULATIONAHA.107.70920418086925
   PubMed Web of Science ®Google Scholar
• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S–e496S. doi:10.1378/chest.11-230122315268
   PubMed Web of Science ®Google Scholar
• Grove JR, Pevec WC. Venous thrombosis related to peripherally inserted central catheters. J Vasc Interv Radiol. 2000;11(7):837–840.10928518
   PubMed Web of Science ®Google Scholar